Send us Feedback

AstraZeneca (AZN)
Analysis
Data
Financials
Revenue by Geography    (USD)
Annual
FISCAL YEAR ENDING older 31-DEC
2004		 31-DEC
2005		 31-DEC
2006		 31-DEC
2007		 31-DEC
2008		 newer
Revenue - Euro Zone 0 0 9T 9.14B 9.94B
Revenue - Rest of World 0 0 4T 0 0
Revenue - Latin America 420M 523M 673M 872M 1.16B
Revenue - US 9.60B 10.7B 12T 13.4B 13.7B
Total Revenue 21.4B 23.9B 26.5B 29.6B 31.6B
Revenue by Segment    (USD)
Annual
FISCAL YEAR ENDING older 31-DEC
2004		 31-DEC
2005		 31-DEC
2006		 31-DEC
2007		 31-DEC
2008		 newer
Revenue - Nexium 0 0 5.18B 5.22B 5.20B
Revenue - Losec/Prilosec 0 0 1.37B 1.14B 1.05B
Revenue - Gastrointestinal other 0 0 78.0 84.0M 89.0M
Revenue - Crestor 0 0 2.03B 2.80B 3.60B
Revenue - Seloken/Toprol-XL 0 0 1.79B 1.44B 807M
Revenue - Atacand 0 0 1.11B 1.29B 1.47B
Revenue - Zestril 0 0 307M 295M 236M
Revenue - Plendil 0 0 275M 271M 268M
Revenue - Symbicort 0 0 1.18B 1.57B 2.00B
Revenue - Pulmicort 0 0 1.29B 1.45B 1.50B
Revenue - Rhinocort 0 0 360M 354M 322M
Revenue - Oxis 0 0 88.0M 86.0M 71.0M
Revenue - Respiratory other 0 0 227M 242M 236M
Revenue - Arimidex 0 0 1.51B 1.73B 1.86B
Revenue - Casodex 0 0 1.21B 1.33B 1.26B
Revenue - Zoladex 0 0 1.01B 1.10B 1.14B
Revenue - Ressa 0 0 237M 238M 265M
Revenue - Faslodex 0 0 186M 214M 249M
Revenue - Nolvadex 0 0 89.0M 83.0M 85.0M
Revenue - Abraxane 0 0 18.0M 62.0M 64.0M
Revenue - Ethyol 0 0 0 43.0M 28.0M
Revenue - Oncology other 0 0 10.0M 10.0M 10.0M
Revenue - Seroquel 0 0 3.42B 4.03B 4.45B
Revenue - Local anaesthetics 0 0 529M 557M 605M
Revenue - Zomig 0 0 398M 434M 448M
Revenue - Diprivan 0 0 304M 263M 278M
Revenue - Neuroscience other 0 0 57.0M 59.0M 54.0M
Revenue - Merrem 0 0 604M 773M 897M
Revenue - Synagis 0 0 0 618M 1.23B
Revenue - FluMist 0 0 0 53.0M 104M
Revenue - Infection Other 0 0 271M 270M 220M
Revenue - Aptium Oncology 0 0 374M 402M 395M
Revenue - Astra Tech 0 0 360M 444M 629M
Total Revenue 21.4B 23.9B 26.5B 29.6B 31.6B
 
 
 
 
 
 
Data Sources:
Market and financial statement data provided by NASDAQ, BATS Exchange, SEC and Xignite Inc. Industry and operating metrics collected from company filings via EDGAR online. For more information on sources and calculations click here.
Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki